and the PLR (median value = 117) were not correlated with disease-specific and overall 5-year survivals. On multivariate analysis, pathological stage I (p=0.01) and GPS 0 (p= 0.04, hazard ratio:
due to other causes, including 3 of pneumonia, 2 of heart failure and fatal arrhythmia, 1 each of interstitial pneumonia, cerebral infarction, rectal cancer, panperitonitis, and an accident, while 3 died of unknown causes. Table 2 shows the characteristics and 5-year survival rates according to potential prognostic factors in the clinical stage I elderly people of this study. Four major prognostic factors, including patient factors (sex, PS, BMI, serum CEA, and CCI), inflammation factors (GPS, NLR, and PLR), surgical factors (procedures and lymph node dissection), and stage factors (clinical and pathological), were investigated.
Analysis of prognostic factors

Patient factors
PS, BMI, and serum CEA value were not significant, but sex was marginally significant (p=0.05).
For CCI, the average score was 1.3 (range: 0-5). Disease-specific 5-year survival was not significantly different between CCI 0,1 and CCI ≥2 (71.6%, 64.4%, respectively, p=0.48) ( Fig.2A) , but overall 5-year survival was significantly longer for CCI 0,1 than for CCI ≥2 (63.2%, 36.5%, respectively, p=0.03) (Fig 2B) .
Inflammatory factors
The average GPS score was 0.4 (range: 0-2). Disease-specific 5-year survival was significantly longer with GPS 0 that with GPS 1-2 (74.1%, 53.7%, respectively, p=0.03) (Fig.3A) . Overall 5-year survival was significantly longer with GPS 0 than with GPS 1-2 (59.7%, 43.1%, respectively, p=0.005) (Fig.3B ). Table 3 shows the patients' characteristics according to GPS. The patients' background characteristics, including patient, inflammatory, surgical, and stage factors, except for the distribution of PLR, were not significantly different among GPS 0, 1, and 2. The median NLR value was 1.9 (range: 0.3-7.5). Disease-specific and overall 5-year survivals were not significantly different overall survival and local recurrence rates between the with and without lymph node dissection groups for elderly patients with clinical stage I NSCLC and concluded that a limited operation without lymph node dissection might be the best surgical treatment for carefully selected elderly patients with clinical stage I NSCLC.
In addition, the small sample size of the present study might affect other typical prognostic factors, PS and CEA [20] . From the results of the present study, we suggest the following for determining the appropriateness of surgery for elderly patients with clinical stage I NSCLC. Surgical candidates basically require a good performance status and preserved respiratory and cardiac functions for procedures, and a low score GPS is desirable. Radical pulmonary resection is not always necessary, and VATS is the best approach [21] because it is less invasive [22] and less painful [23] . On the other hand, a patient with GPS ≥2 might benefit less from surgery. Thus, high GPS would change our clinical practice in regards to management of elderly lung cancer patients.
This study had several limitations. First, this study was retrospective, and the sample population was small and median follow-up of only 2.8 years and obtained from a single institution; small samples and short time of follow-up sometimes affect statistical accuracy. Secondly, since cut-off values of NLR and PLR have not been defined, they might not have been identified as prognostic factors. Thirdly, the long period of time examined (23years) during which many diagnostic and technical advances, such as PET/ CT, VATS and postoperative intensive care evolved. This long period of time would be another selection bias. Thus, we should have limited the analysis to a short time during which all the patient management had been homogenous. Future studies are needed to address these limitations and to determine whether this inflammation-base score could be applied in clinical practice to help determine the appropriateness of surgery for elderly or younger patients, or advanced stage with NSCLC.
In conclusion, to the best of our knowledge, this is the first study to evaluate the prognosis of elderly patients with operable clinical stage I NSCLC using the preoperative GPS. The preoperative GPS should be used routinely in clinical practice, since it appears to be a useful predictor of overall survival and could be a simple, versatile, and objective prognostic tool for elderly patients with clinical stage I NSCLC. 
